April 2, 2008 -- ProGenTech of Shanghai and Emeryville, CA raised $21 million in a Series C financing. The round was led by Bay City Capital of San Francisco and DT Capital of Shanghai. ProGenTech is developing an automated nucleic acid purification system with a cassette-based technology that is designed to keep samples free of user contamination. ProGenTech was established in 2005 and now has 40 employees. Its first product, the Entura, was launched in Asia in November 2007. More details...
